Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B revaccination strategies in healthy vaccine non-responders
NL-OMON41474Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of Recombivax HB, Hepatitis B vaccine and hepatitis b vaccine recombinant in hepatitis B (HBV) (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Anti-HBs antibody titer after revaccination. Started Nov 2012; status: active, not recruiting.
02
Drugs
Recombivax HBHepatitis B vaccinehepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON41474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41474.